Gagnon Advisors
$182M 13F equity value
25 Holdings
Quarter ended September 30, 2026
The latest 13F on file for Gagnon Advisors covers the quarter ended September 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| CDNA | CAREDX INC | 286,889 | $19M | 10.2% |
| EPD | ENTERPRISE PRODS PARTNERS L P | 339,877 | $12M | 6.6% |
| WGS | GENEDX HOLDINGS CORP | 163,024 | $12M | 6.5% |
| FIVN | FIVE9 INC | 336,277 | $11M | 6.3% |
| HNGE | HINGE HEALTH INC | 113,304 | $11M | 6.1% |
| EQIX | EQUINIX INC | 10,715 | $11M | 6.0% |
| BLFS | BIOLIFE SOLUTIONS INC | 274,217 | $11M | 5.9% |
| FRSH | FRESHWORKS INC | 776,212 | $10M | 5.5% |
| AMRC | AMERESCO INC | 472,798 | $10M | 5.4% |
| PCRX | PACIRA BIOSCIENCES INC | 352,637 | $9M | 4.9% |
Track Gagnon Advisors's 13F portfolio: $182M in reported holdings, 25 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}